Overview

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Droperidol
Esketamine
Gabapentin
Ketamine
Lidocaine
Criteria
Inclusion Criteria:

- Elective laparoscopic cholecystectomy

- Age above 18 years

- Written informed consent

- ASA class I-III

Exclusion Criteria:

- Planned abdominal cholecystectomy

- Intraoperative conversion of laparoscopic to laparotomic cholecystectomy

- Allergy to part of the treatment regimens

- Previous reactions to opioids (nausea, cognition)